Indonesia Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Indonesia Pharmaceuticals and Healthcare Report Q3 2013 Jul 24th 2013, 00:00, by jayshree BMI View: Theoretically, considerable opportunities for pharmaceutical manufacturers exist in relation to the Indonesian pharmaceutical market. Demand for medicines will continue to be supported by the country’s large population, the rollout of the universal healthcare programme in 2014 (with the ultimate aim to cover all Indonesians by 2019) and the expansion of healthcare services. However, Indonesia will remain a risky operating environment, with market access hampered by a range of intellectual property barriers and the government’s biased stance against foreign companies. Headline Expenditure Projections ? Pharmaceuticals: IDR58,553bn (US$6.25bn) in 2012 to IDR63,915bn (US$6.56bn) in 2013; +9.2% growth in local currency … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=108328. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/indonesia-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions